FDAFDA · Food and drugs·Recall number D-0160-2024
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10
Published January 3, 2024 · Recall initiated: December 12, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ANORO ELLIPTA
- Manufacturer
- GlaxoSmithKline LLC
- Distributor
- Distributed Nationwide in the USA and Puerto Rico.
- Lot
- Lot #: 7Y9S. Exp June 2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.